Coronavirus Update: Hudson’s Remarks On US ‘First Rights’ Stirs Vaccine Row
Draws Criticism From French Government
Company clarifies by saying it has production capacity in Europe as well as US and other regions - but follows Hudson's calls for Europe to develop its own BARDA-like agency.
You may also be interested in...
Paul Hudson has been at the helm of Sanofi for just nine months, but for the last few days his comments about which country will be first in line for the firm's coronavirus vaccines will have reminded him that the Gallic culture runs deep.
Plus: Eli Lilly extends its presence in COVID-19 research with an alliance with China's Junshi Biosciences.
With a new CEO at the helm, Gamida is closing in on an FDA approval, but a lack of cash could hobble its US launch efforts for allogeneic cell therapy product omidubicel.